- Home
- GOSS vs MPB Comparison
GOSS vs MPB Comparison
Compare GOSS & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- MPB
- Stock Information
- Founded
- GOSS 2015
- MPB 1868
- Country
- GOSS United States
- MPB United States
- Employees
- GOSS N/A
- MPB N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- MPB Major Banks
- Sector
- GOSS Health Care
- MPB Finance
- Exchange
- GOSS Nasdaq
- MPB Nasdaq
- Market Cap
- GOSS 586.6M
- MPB 691.1M
- IPO Year
- GOSS 2019
- MPB N/A
- Fundamental
- Price
- GOSS $3.08
- MPB $31.64
- Analyst Decision
- GOSS Strong Buy
- MPB Buy
- Analyst Count
- GOSS 6
- MPB 2
- Target Price
- GOSS $8.60
- MPB $34.50
- AVG Volume (30 Days)
- GOSS 4.8M
- MPB 89.6K
- Earning Date
- GOSS 11-06-2025
- MPB 10-22-2025
- Dividend Yield
- GOSS N/A
- MPB 2.55%
- EPS Growth
- GOSS N/A
- MPB N/A
- EPS
- GOSS N/A
- MPB 2.30
- Revenue
- GOSS $40,237,000.00
- MPB $191,454,000.00
- Revenue This Year
- GOSS N/A
- MPB $24.57
- Revenue Next Year
- GOSS $34.10
- MPB $12.23
- P/E Ratio
- GOSS N/A
- MPB $13.65
- Revenue Growth
- GOSS N/A
- MPB 13.34
- 52 Week Low
- GOSS $0.66
- MPB $22.50
- 52 Week High
- GOSS $3.60
- MPB $33.87
- Technical
- Relative Strength Index (RSI)
- GOSS 61.72
- MPB 74.26
- Support Level
- GOSS $2.93
- MPB $29.94
- Resistance Level
- GOSS $3.37
- MPB $30.44
- Average True Range (ATR)
- GOSS 0.29
- MPB 0.63
- MACD
- GOSS 0.01
- MPB 0.05
- Stochastic Oscillator
- GOSS 57.55
- MPB 99.72
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.